Hudu, S.A.; Elmigdadi, F.; Qtaitat, A.A.; Almehmadi, M.; Alsaiari, A.A.; Allahyani, M.; Aljuaid, A.; Salih, M.; Alghamdi, A.; Alrofaidi, M.A.;
et al. Trofinetide for Rett Syndrome: Highlights on the Development and Related Inventions of the First USFDA-Approved Treatment for Rare Pediatric Unmet Medical Need. J. Clin. Med. 2023, 12, 5114.
https://doi.org/10.3390/jcm12155114
AMA Style
Hudu SA, Elmigdadi F, Qtaitat AA, Almehmadi M, Alsaiari AA, Allahyani M, Aljuaid A, Salih M, Alghamdi A, Alrofaidi MA,
et al. Trofinetide for Rett Syndrome: Highlights on the Development and Related Inventions of the First USFDA-Approved Treatment for Rare Pediatric Unmet Medical Need. Journal of Clinical Medicine. 2023; 12(15):5114.
https://doi.org/10.3390/jcm12155114
Chicago/Turabian Style
Hudu, Shuaibu A., Fayig Elmigdadi, Aiman Al Qtaitat, Mazen Almehmadi, Ahad Amer Alsaiari, Mamdouh Allahyani, Abdulelah Aljuaid, Magdi Salih, Adel Alghamdi, Mohammad A. Alrofaidi,
and et al. 2023. "Trofinetide for Rett Syndrome: Highlights on the Development and Related Inventions of the First USFDA-Approved Treatment for Rare Pediatric Unmet Medical Need" Journal of Clinical Medicine 12, no. 15: 5114.
https://doi.org/10.3390/jcm12155114
APA Style
Hudu, S. A., Elmigdadi, F., Qtaitat, A. A., Almehmadi, M., Alsaiari, A. A., Allahyani, M., Aljuaid, A., Salih, M., Alghamdi, A., Alrofaidi, M. A., Abida, & Imran, M.
(2023). Trofinetide for Rett Syndrome: Highlights on the Development and Related Inventions of the First USFDA-Approved Treatment for Rare Pediatric Unmet Medical Need. Journal of Clinical Medicine, 12(15), 5114.
https://doi.org/10.3390/jcm12155114
